Molecular Genetics and Genetic Diseases
A section of Biomedicines (ISSN 2227-9059).
Section Information
The section “Molecular Genetics and Genetic Diseases” covers the basic and translational aspects of human genetic diseases and genomics research, from fundamental molecular investigation to preclinical animal models. In particular, this section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the treatment of genetic disorders, and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics and bioinformatic tools to advance knowledge in human genetic diseases.
Topics within the scope of this section include, but are not limited to:
- Chromosome organization, structure, and function; chromatin remodeling and dynamics, chromosomal maintenance elements;
- DNA replication, repair, recombination, mobile DNA, mitochondrial DNA;
- DNA methylation, histone modification, histone code;
- RNA biology, transcription and splicing, coding and non-coding RNA analysis, RNA localization, translation and catalysis by RNA;
- Post-transcriptional regulation of gene expression;
- Genetic toxicology and environmental mutagenesis;
- Genetics of monogenic diseases and complex diseases; genotype–phenotype relationships;
- Precision medicine; pharmacogenetics and pharmacogenomics;
- Targeted genome editing; gene therapy and delivery systems; genetically-engineered cell therapy
- RNA and small nucleic acid-based therapeutics;
- Genetic testing and molecular diagnostics; biomarker development and application; genome-wide association studies;
- Epigenetic therapy; cancer immunotherapy;
- Developmental genetics; epigenetics and epigenomics.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Human Non-Mendelian Inheritance Disorders (Deadline: 31 March 2024)
- Genetics and Epigenetics of Kidney Diseases (Deadline: 31 March 2024)
- Transcriptomics in Human Health and Disease (Deadline: 31 March 2024)
- Advances and Applications of Regulatory Genomics in Multiple Myeloma (Deadline: 31 March 2024)
- Biological Mechanisms in Symptom Clustering: Insights from Genomic and Proteomic (Deadline: 30 April 2024)
- Genetic and Epigenetic Regulation in Cardiovascular Diseases: Omics-Based Approaches (Deadline: 30 April 2024)
- Technologies and Methods for Studying Epitranscriptomes (Deadline: 30 April 2024)
- Advanced Research of HLA in Diseases (Deadline: 30 April 2024)
- Regulation of the Hypoxic Response by Noncoding RNA (Deadline: 30 April 2024)
- Molecular and Genetic Bases of Infertility (Deadline: 31 May 2024)
- Genetic and Epigenetics of Kidney Development: Pathologies of Renal Anomalies and Kidney Diseases (Deadline: 30 June 2024)
- Kidney Disease: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 30 June 2024)
- Genetic and Molecular Mechanisms of Cardiometabolic Diseases and Cancers (Deadline: 30 June 2024)
- Cardiovascular Proteomics (Deadline: 30 June 2024)
- Genetic Research on Colorectal Cancer (Deadline: 30 June 2024)
- Molecular Basis and Translational Research in Genetic Myopathies (Deadline: 31 August 2024)
- Gene Delivery and Gene Editing (Deadline: 31 August 2024)
- Molecular Biomarkers of Tumors: Advancing Genetic Studies (Deadline: 15 September 2024)
- Hemoglobin Molecule: A Structure-Function Interplay (Deadline: 30 September 2024)
- Molecular Processes Underlying Pathogenesis and Advanced Therapies for Genodermatosis (Deadline: 30 September 2024)